| Drug repurposing: re-inventing therapies for cancer without re-entering the development pipeline—a review S Siddiqui, AJ Deshmukh, P Mudaliar, AJ Nalawade, D Iyer, J Aich Journal of the Egyptian National Cancer Institute 34 (1), 33, 2022 | 12 | 2022 |
| Synergistic combination of ritonavir and cisplatin as an efficacious therapy in human cervical cancer cells: a computational drug discovery and in vitro insight D Swami, P Mudaliar, YS Bichu, V Kumar Sahu, S Devarajan, S Basu, ... Journal of Biomolecular Structure and Dynamics 41 (12), 5802-5816, 2023 | 3 | 2023 |
| Tumor-derived exosome and immune modulation DS Chauhan, P Mudaliar, S Basu, J Aich, MK Paul Extracellular Vesicles-Role in Diseases, Pathogenesis and Therapy, 2022 | 2 | 2022 |
| Therapeutic potential of autophagy activators and inhibitors in lung and breast cancer-a review P Mudaliar, A Nalawade, S Devarajan, J Aich Molecular Biology Reports 49 (11), 10783-10795, 2022 | 1 | 2022 |
| Anti-Cancer Phytopharmaceuticals: A Green Approach Towards Treating Cancer P Mudaliar, AJ Nalawade, P Arte, A Dhuliya, D Iyer, K Tungare, M Bhori, ... Phytopharmaceuticals and Biotechnology of Herbal Plants, 239-254, 2022 | | 2022 |
| Imaging as an Important Tool for Diagnosis of Breast Cancer P Mudaliar, S Siddiqui, S Ballav, NR Shankar, S Basu, J Aich Latest Advances in Diagnosis and Treatment of Women-Associated Cancers, 25-35, 2022 | | 2022 |
| IDENTIFICATION OF A POTENT AUTOPHAGY INHIBITOR IN LUNG AND BREAST CANCER P Mudaliar, A Nalawade, S Devarajan, J Aich Journal of Advanced Scientific Research 2021 (HBIA), 35-46, 2021 | | 2021 |
Dr. Jyotirmoi AichSenior Manager, MicroCRISPRVerified email at microcrispr.com
